Despite these specific differences, the overall findings from these researchers converge on the conclusion that CDX2-negative tumors frequently exhibit forms of aggressive invasion, consistently emphasizing the marker’s predictive value regarding tumor aggressiveness [34,42,43]. The gene discussed is CDX2; the disease is neoplasm.